Copyright © 2004 by the European Society of Cardiology.
Preclinical research
A novel mutation, Ser143Pro, in the lamin A/C gene is common in finnish patients with familial dilated cardiomyopathy
a Department of Medicine, University of Kuopio, P.O. Box 1777, Kuopio, Finland
b Department of Medicine, University of Helsinki, Helsinki, Finland
* Corresponding author. Tel.: +358-17173956; fax: +358-17173959
E-mail address: keijo.peuhkurinen{at}kuh.fi
Received 3 August 2003; revised 1 January 2004; accepted 22 January 2004 See page 812, for the editorial comment on this article.1
Abstract
Aims The mutations most frequently associated with dilated cardiomyopathy (DCM) have been reported in the lamin A/C gene. The role of variants of the lamin A/C gene was investigated in patients with DCM from eastern and southern Finland.
Methods and results All 12 exons of the lamin A/C gene were screened in 18 well-characterised familial DCM patients from eastern and southern Finland and in 72 sporadic DCM patients from eastern Finland using the PCR-SSCP method. A novel mutation, Ser143Pro (S143P), was detected in the lamin A/C gene in 24 subjects from 5 unrelated families and in one sporadic case of DCM. Sinus or atrioventricular nodal dysfunction occurred in the majority of the affected subjects, many of which required pacemaker implantation. Seven patients (28%) with the S143P mutation died suddenly or from progressive heart failure, or underwent heart transplantation. The haplotypes 5–5–5–3, 5–5–5–2, and 5–5–5–1 co-segregated with the Ser143Pro mutation, suggesting a founder effect of this mutation.
Conclusions A novel mutation S143P in the lamin A/C gene was found to be common among Finnish DCM patients. Haplotype analysis strongly suggests a founder effect of this mutation. The phenotype is characterised by severe heart failure, progressive atrioventricular conduction defects, and sudden death. Screening for the lamin A/C gene and, particularly, the S143P mutation seems warranted when patients with DCM have conduction system disturbances.
Key Words: Dilated cardiomyopathy • Lamin A/C gene
CiteULike 
Connotea 
Del.icio.us What's this?
Related articles in EHJ:
- Often seen but rarely recognised: cardiac complications of lamin A/C mutations
- Jop H van Berlo, Denis Duboc, and Yigal M Pinto
EHJ 2004 25: 812-814.[Extract] [Full Text]
This article has been cited by other articles:
|
|
 |
|
  S. Kandert, Y. Luke, T. Kleinhenz, S. Neumann, W. Lu, V. M. Jaeger, M. Munck, M. Wehnert, C. R. Muller, Z. Zhou, et al. Nesprin-2 giant safeguards nuclear envelope architecture in LMNA S143F progeria cells Hum. Mol. Genet., December 1, 2007; 16(23): 2944 - 2959. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. van Tintelen, R. A. Tio, W. S. Kerstjens-Frederikse, J. H. van Berlo, L. G. Boven, A. J.H. Suurmeijer, S. J. White, J. T. den Dunnen, G. J. te Meerman, Y. J. Vos, et al. Severe Myocardial Fibrosis Caused by a Deletion of the 5' End of the Lamin A/C Gene J. Am. Coll. Cardiol., June 26, 2007; 49(25): 2430 - 2439. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. V. Broers, F. C. S. Ramaekers, G. Bonne, R. B. Yaou, and C. J. Hutchison Nuclear lamins: laminopathies and their role in premature ageing. Physiol Rev, July 1, 2006; 86(3): 967 - 1008. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Karkkainen, E Reissell, T Helio, M Kaartinen, P Tuomainen, L Toivonen, J Kuusisto, M Kupari, M S Nieminen, M Laakso, et al. Novel mutations in the lamin A/C gene in heart transplant recipients with end stage dilated cardiomyopathy. Heart, April 1, 2006; 92(4): 524 - 526. [Full Text] [PDF]
|
|
|
|
 |
|
 J. H van Berlo, D. Duboc, and Y. M Pinto Often seen but rarely recognised: cardiac complications of lamin A/C mutations Eur. Heart J., May 2, 2004; 25(10): 812 - 814. [Full Text] [PDF]
|
|